Macrolide-based regimens in absence of bacterial co-infection in critically ill H1N1 patients with primary viral pneumonia (Q30426227)

21 June 2017

title

Macrolide-based regimens in absence of bacterial co-infection in critically ill H1N1 patients with primary viral pneumonia (English)

1 reference

21 June 2017

0 references

0 references

1 reference

Jose Garnacho-Montero

0 references

Loreto Santa Marina

1 reference

ORCID Public Data File 2021

author name string

I Martín-Loeches

1

1 reference

21 June 2017

J F Bermejo-Martin

2

1 reference

21 June 2017

J Vallés

3

1 reference

21 June 2017

R Granada

4

1 reference

21 June 2017

L Vidaur

5

1 reference

21 June 2017

J C Vergara-Serrano

6

1 reference

21 June 2017

M Martín

7

1 reference

21 June 2017

J C Figueira

8

1 reference

21 June 2017

J M Sirvent

9

1 reference

21 June 2017

J Blanquer

10

1 reference

21 June 2017

D Suarez

11

1 reference

21 June 2017

A Artigas

12

1 reference

21 June 2017

A Torres

13

1 reference

21 June 2017

E Diaz

14

1 reference

21 June 2017

A Rodriguez

15

1 reference

21 June 2017

SEMICYUC/REIPI/CIBERES H1N1 Working Group

16

1 reference

21 June 2017

publication date

24 January 2013

1 reference

21 June 2017

published in

Intensive Care Medicine

1 reference

21 June 2017

volume

39

1 reference

21 June 2017

issue

4

1 reference

21 June 2017

page(s)

693-702

1 reference

Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2829-8

Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2829-8

Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2829-8

Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2829-8

Critically ill patients with 2009 influenza A(H1N1) infection in Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2829-8

Critical care services and 2009 H1N1 influenza in Australia and New Zealand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2829-8

Community-acquired respiratory coinfection in critically ill patients with pandemic 2009 influenza A(H1N1) virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2829-8

Impact of obesity in patients infected with 2009 influenza A(H1N1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2829-8

Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2829-8

Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: analytic strategy using propensity scores

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2829-8

Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2829-8

Benefit of early treatment with oseltamivir in hospitalized patients with documented 2009 influenza A (H1N1): retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2829-8

2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2829-8

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2829-8

Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2829-8

Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2829-8

Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2829-8

Impact of initial antibiotic choice on clinical outcomes in community-acquired pneumonia: analysis of a hospital claims-made database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2829-8

The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2829-8

Impact of intravenous {beta}-lactam/macrolide versus {beta}-lactam monotherapy on mortality in hospitalized patients with community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2829-8

Macrolide immunomodulation of chronic respiratory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2829-8

Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2829-8

Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2829-8

Therapeutic effect of erythromycin on influenza virus-induced lung injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2829-8

Effect of immunomodulatory therapies in patients with pandemic influenza A (H1N1) 2009 complicated by pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2829-8

Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2829-8

Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2829-8

[Guidelines for the diagnosis and management of community-acquired pneumonia. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR)]

21 January 2018

1 reference

12 December 2020

Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia

1 reference

12 December 2020

The value of routine microbial investigation in community-acquired pneumonia

1 reference

12 December 2020

Macrolides inhibit IL17-induced IL8 and 8-isoprostane release from human airway smooth muscle cells

1 reference

12 December 2020

Macrolides for the treatment of severe respiratory illness caused by novel H1N1 swine influenza viral strains

1 reference

12 December 2020

Antibiotics for bacteremic pneumonia: Improved outcomes with macrolides but not fluoroquinolones

1 reference

12 December 2020

Combination Antibiotic Therapy Lowers Mortality among Severely Ill Patients with Pneumococcal Bacteremia

1 reference

12 December 2020

Adjunctive Therapy in Community-Acquired Pneumonia

1 reference

12 December 2020

Clinical implications of the immunomodulatory effects of macrolides

1 reference

12 December 2020

Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia

1 reference

12 December 2020

Clarithromycin in the treatment of RSV bronchiolitis: a double-blind, randomised, placebo-controlled trial

1 reference

12 December 2020

Normativas para el diagnóstico y el tratamiento de la neumonía adquirida en la comunidad. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)

1 reference

12 December 2020

10.1007/S00134-013-2829-8

Identifiers

DOI

1 reference

21 June 2017

1 reference